Suppr超能文献

轻度、未使用过类固醇的哮喘患者中,单磷酸腺苷支气管激发试验的可重复性。

The reproducibility of adenosine monophosphate bronchial challenges in mild, steroid-naive asthmatics.

作者信息

Singh Dave, Fairwood Jennifer, Murdoch Robert, Weeks Amanda, Russell Paul, Roy Kay, Langley Steve, Woodcock Ashley

机构信息

North West Lung Research Centre, University of Manchester, South Manchester University Hospitals Trust, Manchester, UK.

出版信息

Br J Clin Pharmacol. 2008 Aug;66(2):261-5. doi: 10.1111/j.1365-2125.2008.03186.x. Epub 2008 May 27.

Abstract

AIMS

Repeated adenosine monophosphate (AMP) challenges are used to assess drug efficacy in clinical trials of mild, steroid-naive asthmatics. Refractoriness has been reported after repeated challenges over short intervals. This study evaluated possible tachyphylaxis after repeated AMP challenges at 12 and 24 h in mild, steroid-naive asthmatics.

METHODS

This was an open, three-way crossover study. Twenty-six steroid-naive asthmatic subjects were randomized to the following AMP challenge regimens separated by 7-14 days: (A) challenge at 08.00 h, repeated 24 h later; (B) challenge at 08.00 h, repeated 12 and 24 h later; (C) challenge at 20.00 h, repeated 12 h later. Comparisons within day were assessed using 90% confidence intervals (CIs). Non-inferiority approach taken with 1 doubling concentration (DC) as a clinically relevant difference.

RESULTS

Regimen A: Significant increase in AMP reactivity at 24 h. Mean DC difference was 0.6 (90% CI 0.24, 0.96). Regimen B: No evidence of difference between AMP reactivity at 08.00 h and a repeated challenge 12 h later. Repeated challenge at 24 h caused a significant increase in provocation concentration (PC)(20) compared with 12 h (mean DC difference 0.48, 90% CI 0.02, 0.95) and 0 h (mean DC difference 0.82, 90% CI 0.49, 1.14 - the upper CI exceeds the criteria of 1 DC). Challenge regimen C: No difference between challenges; mean DC difference of 0.28 (90% CI -0.2, 0.76).

CONCLUSION

The small decline in AMP reactivity during repeated challenges was not consistently observed, and was small compared with the known effects of inhaled drugs.

摘要

目的

在轻度、未使用过类固醇的哮喘患者的临床试验中,反复进行单磷酸腺苷(AMP)激发试验用于评估药物疗效。有报道称在短时间间隔内反复激发后会出现不应性。本研究评估了轻度、未使用过类固醇的哮喘患者在12小时和24小时反复进行AMP激发试验后可能出现的快速减敏反应。

方法

这是一项开放性、三向交叉研究。26名未使用过类固醇的哮喘受试者被随机分为以下AMP激发试验方案,间隔7 - 14天:(A)08:00进行激发试验,24小时后重复;(B)08:00进行激发试验,12小时和24小时后重复;(C)20:00进行激发试验,12小时后重复。日内比较采用90%置信区间(CI)进行评估。采用非劣效性方法,将1倍加倍浓度(DC)作为临床相关差异。

结果

方案A:24小时时AMP反应性显著增加。平均DC差异为0.6(90%CI 0.24,0.96)。方案B:08:00时的AMP反应性与12小时后重复激发试验之间无差异证据。与12小时相比,24小时重复激发试验导致激发浓度(PC)(20)显著增加(平均DC差异0.48,90%CI 0.02,0.95),与0小时相比(平均DC差异0.82,90%CI 0.49,1.14 - 上CI超过1 DC标准)。激发试验方案C:两次激发试验之间无差异;平均DC差异为0.28(90%CI -0.2,0.76)。

结论

在反复激发试验期间,AMP反应性的小幅下降并非始终可见,并且与吸入药物的已知效果相比幅度较小。

相似文献

本文引用的文献

4
Indirect airway challenges.间接气道激发试验
Eur Respir J. 2003 Jun;21(6):1050-68. doi: 10.1183/09031936.03.00008403.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验